IL147902A0 - C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof - Google Patents
C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereofInfo
- Publication number
- IL147902A0 IL147902A0 IL14790200A IL14790200A IL147902A0 IL 147902 A0 IL147902 A0 IL 147902A0 IL 14790200 A IL14790200 A IL 14790200A IL 14790200 A IL14790200 A IL 14790200A IL 147902 A0 IL147902 A0 IL 147902A0
- Authority
- IL
- Israel
- Prior art keywords
- prostate cancer
- human prostate
- antigen expressed
- type lectin
- transmembrane antigen
- Prior art date
Links
- 206010060862 Prostate cancer Diseases 0.000 title abstract 4
- 208000000236 Prostatic Neoplasms Diseases 0.000 title abstract 4
- 102000003930 C-Type Lectins Human genes 0.000 title 1
- 108090000342 C-Type Lectins Proteins 0.000 title 1
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 239000002523 lectin Substances 0.000 abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 210000001550 testis Anatomy 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/7056—Lectin superfamily, e.g. CD23, CD72
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57434—Specifically defined cancers of prostate
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Hospice & Palliative Care (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Oncology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14893599P | 1999-08-12 | 1999-08-12 | |
PCT/US2000/022065 WO2001012811A1 (en) | 1999-08-12 | 2000-08-11 | C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
IL147902A0 true IL147902A0 (en) | 2002-08-14 |
Family
ID=22528098
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14790200A IL147902A0 (en) | 1999-08-12 | 2000-08-11 | C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
IL147902A IL147902A (en) | 1999-08-12 | 2002-01-30 | C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
IL197988A IL197988A (en) | 1999-08-12 | 2009-04-05 | Antibody or fragment thereof that specifically binds to a pc-lectin polypeptide |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL147902A IL147902A (en) | 1999-08-12 | 2002-01-30 | C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
IL197988A IL197988A (en) | 1999-08-12 | 2009-04-05 | Antibody or fragment thereof that specifically binds to a pc-lectin polypeptide |
Country Status (13)
Country | Link |
---|---|
US (6) | US6602501B1 (es) |
EP (2) | EP1200590B1 (es) |
JP (3) | JP4373637B2 (es) |
AT (2) | ATE420175T1 (es) |
AU (5) | AU774436B2 (es) |
CA (1) | CA2380550C (es) |
CY (2) | CY1110256T1 (es) |
DE (2) | DE60045201D1 (es) |
DK (2) | DK1992695T3 (es) |
ES (2) | ES2355428T3 (es) |
IL (3) | IL147902A0 (es) |
PT (2) | PT1200590E (es) |
WO (1) | WO2001012811A1 (es) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020137890A1 (en) * | 1997-03-31 | 2002-09-26 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
DK1169442T3 (da) * | 1999-03-23 | 2006-10-16 | Genentech Inc | Secernerede polypeptider og transmembran-polypeptider og nukleinsyrer, der koder for disse |
AU2005205755B2 (en) * | 1999-03-23 | 2007-10-04 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
EP1046651A1 (en) * | 1999-04-19 | 2000-10-25 | Koninklijke Universiteit Nijmegen | Composition and method for modulating dendritic cell-T interaction |
US7842458B2 (en) | 1999-08-12 | 2010-11-30 | Agensys, Inc. | Nucleic acids and corresponding proteins entitled 58P1D12 useful in treatment and detection of cancer |
JP4373637B2 (ja) | 1999-08-12 | 2009-11-25 | アジェンシス,インコーポレイテッド | ヒト前立腺癌において発現されるc型レクチン膜貫通抗原およびその使用 |
US7449548B2 (en) | 2001-12-07 | 2008-11-11 | Agensys, Inc. | Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer |
TW200413725A (en) * | 2002-09-30 | 2004-08-01 | Oncotherapy Science Inc | Method for diagnosing non-small cell lung cancers |
WO2006022722A1 (en) * | 2004-08-16 | 2006-03-02 | Agensys, Inc. | Nucleic acids and corresponding proteins entitled 58p1d12 useful in treatment and detection of cancer |
US9492400B2 (en) * | 2004-11-04 | 2016-11-15 | Massachusetts Institute Of Technology | Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals |
GB0426822D0 (en) * | 2004-12-07 | 2005-01-12 | Precisense As | Sensor for detection of glucose |
GB0426823D0 (en) * | 2004-12-07 | 2005-01-12 | Precisense As | Sensor for detection of glucose |
WO2007070682A2 (en) * | 2005-12-15 | 2007-06-21 | Massachusetts Institute Of Technology | System for screening particles |
CA2648099C (en) | 2006-03-31 | 2012-05-29 | The Brigham And Women's Hospital, Inc | System for targeted delivery of therapeutic agents |
CN101573141B (zh) | 2006-05-15 | 2016-05-04 | 麻省理工学院 | 用于功能性颗粒的聚合物 |
US20110052697A1 (en) * | 2006-05-17 | 2011-03-03 | Gwangju Institute Of Science & Technology | Aptamer-Directed Drug Delivery |
WO2007150030A2 (en) | 2006-06-23 | 2007-12-27 | Massachusetts Institute Of Technology | Microfluidic synthesis of organic nanoparticles |
US20100303723A1 (en) * | 2006-11-20 | 2010-12-02 | Massachusetts Institute Of Technology | Drug delivery systems using fc fragments |
US9217129B2 (en) * | 2007-02-09 | 2015-12-22 | Massachusetts Institute Of Technology | Oscillating cell culture bioreactor |
WO2008124632A1 (en) | 2007-04-04 | 2008-10-16 | Massachusetts Institute Of Technology | Amphiphilic compound assisted nanoparticles for targeted delivery |
WO2008124634A1 (en) | 2007-04-04 | 2008-10-16 | Massachusetts Institute Of Technology | Polymer-encapsulated reverse micelles |
BRPI0817664A2 (pt) | 2007-10-12 | 2015-03-24 | Massachusetts Inst Technology | Nanopartículas, método para preparar nanopartículas e método para tratar terapeuticamente ou profilaticamente um indivíduo |
WO2010022279A1 (en) * | 2008-08-20 | 2010-02-25 | Agensys, Inc. | Antibodies and related molecules that bind to 58p1d12 proteins |
US8277812B2 (en) | 2008-10-12 | 2012-10-02 | Massachusetts Institute Of Technology | Immunonanotherapeutics that provide IgG humoral response without T-cell antigen |
US8343497B2 (en) | 2008-10-12 | 2013-01-01 | The Brigham And Women's Hospital, Inc. | Targeting of antigen presenting cells with immunonanotherapeutics |
US8591905B2 (en) | 2008-10-12 | 2013-11-26 | The Brigham And Women's Hospital, Inc. | Nicotine immunonanotherapeutics |
US8343498B2 (en) | 2008-10-12 | 2013-01-01 | Massachusetts Institute Of Technology | Adjuvant incorporation in immunonanotherapeutics |
CN105238781B (zh) * | 2015-11-06 | 2018-02-16 | 福建省农业科学院果树研究所 | 基于转录组序列开发的李ssr标记引物对及其应用 |
US10792378B2 (en) | 2017-04-28 | 2020-10-06 | Medtronics Minimed, Inc. | Using a blue-shifted reference dye in an optical glucose assay |
US10543288B2 (en) | 2017-04-28 | 2020-01-28 | Medtronic Minimed, Inc. | Modified-dextrans for use in optical glucose assays |
Family Cites Families (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
JPS6023084B2 (ja) | 1979-07-11 | 1985-06-05 | 味の素株式会社 | 代用血液 |
US4640835A (en) | 1981-10-30 | 1987-02-03 | Nippon Chemiphar Company, Ltd. | Plasminogen activator derivatives |
US4870009A (en) | 1982-11-22 | 1989-09-26 | The Salk Institute For Biological Studies | Method of obtaining gene product through the generation of transgenic animals |
US4496689A (en) | 1983-12-27 | 1985-01-29 | Miles Laboratories, Inc. | Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer |
US4736866B1 (en) | 1984-06-22 | 1988-04-12 | Transgenic non-human mammals | |
EP0206448B1 (en) | 1985-06-19 | 1990-11-14 | Ajinomoto Co., Inc. | Hemoglobin combined with a poly(alkylene oxide) |
US4791192A (en) | 1986-06-26 | 1988-12-13 | Takeda Chemical Industries, Ltd. | Chemically modified protein with polyethyleneglycol |
GB8724885D0 (en) | 1987-10-23 | 1987-11-25 | Binns M M | Fowlpox virus promotors |
US5225538A (en) | 1989-02-23 | 1993-07-06 | Genentech, Inc. | Lymphocyte homing receptor/immunoglobulin fusion proteins |
US4975287A (en) | 1989-09-01 | 1990-12-04 | Wm. Wrigley Jr. Company | Gum composition containing protein macrocolloids |
US5723286A (en) | 1990-06-20 | 1998-03-03 | Affymax Technologies N.V. | Peptide library and screening systems |
JP3179481B2 (ja) | 1990-06-27 | 2001-06-25 | プリンストン ユニバーシティ | 突然変異体p53検出用プローブ |
US5733731A (en) | 1991-10-16 | 1998-03-31 | Affymax Technologies N.V. | Peptide library and screening method |
US5879898A (en) * | 1992-11-20 | 1999-03-09 | Isis Innovation Limited | Antibodies specific for peptide corresponding to CD44 exon 6, and use of these antibodies for diagnosis of tumors |
CH686982A5 (fr) | 1993-12-16 | 1996-08-15 | Maurice Stroun | Méthode pour le diagnostic de cancers. |
DK0773952T3 (da) | 1994-07-20 | 2004-03-22 | Inst Genetics Llc | Interaktionsfældesystemer til påvisning af proteininteraktioner |
US5919652A (en) | 1994-11-09 | 1999-07-06 | The Regents Of The University Of California | Nucleic acid molecules comprising the prostate specific antigen (PSA) promoter and uses thereof |
CA2217545A1 (en) | 1995-04-11 | 1996-10-17 | Marc Vidal | Reverse two-hybrid systems |
US5681923A (en) * | 1995-10-06 | 1997-10-28 | Platt; David | Tumor derived carbohydrate binding protein |
US6476192B1 (en) * | 1996-04-15 | 2002-11-05 | Nicola C. Lally | Recombinant antigens useful for the serodiagnosis of neosporosis |
US6117977A (en) * | 1996-04-24 | 2000-09-12 | Genentech, Inc. | Type C lectins |
US5928868A (en) | 1996-04-26 | 1999-07-27 | Massachusetts Institute Of Technology | Three hybrid screening assay |
US5925523A (en) | 1996-08-23 | 1999-07-20 | President & Fellows Of Harvard College | Intraction trap assay, reagents and uses thereof |
ATE371721T1 (de) | 1996-10-15 | 2007-09-15 | Univ California | Tiermodelle für die menschliche prostatakrebsfortschreitung |
US5846722A (en) | 1996-10-16 | 1998-12-08 | Terrapin Technologies, Inc. | System to detect small molecule/peptide interaction |
KR20080059467A (ko) | 1996-12-03 | 2008-06-27 | 아브게닉스, 인크. | 복수의 vh 및 vk 부위를 함유하는 사람 면역글로불린유전자좌를 갖는 형질전환된 포유류 및 이로부터 생성된항체 |
US7435793B2 (en) | 1998-05-15 | 2008-10-14 | Genentech, Inc. | Peptides that induce chondrocyte redifferentiation |
US20020137890A1 (en) | 1997-03-31 | 2002-09-26 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
US20030004311A1 (en) | 1997-06-18 | 2003-01-02 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
US20030087344A1 (en) * | 1997-06-18 | 2003-05-08 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
US20030022239A1 (en) | 1997-06-18 | 2003-01-30 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
US20030166104A1 (en) | 1997-09-18 | 2003-09-04 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
US20030073169A1 (en) | 1997-09-18 | 2003-04-17 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
US7160985B2 (en) | 1997-10-29 | 2007-01-09 | Genentech, Inc. | Pro180 polypeptide |
US7256039B2 (en) | 1998-05-15 | 2007-08-14 | Genentech, Inc. | PRO4405 nucleic acids |
IL139988A0 (en) | 1998-06-01 | 2002-02-10 | Urogenesys Inc | Tumor antigen useful in diagnosis and therapy of prostate and colon cancer |
EP1100869A4 (en) | 1998-07-30 | 2005-04-27 | Human Genome Sciences Inc | 98 HUMAN SECRETED PROTEINS |
US20030050465A1 (en) | 1998-08-10 | 2003-03-13 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
WO2000039296A1 (en) | 1998-12-23 | 2000-07-06 | Immunex Corporation | Lectin s3939 dna and polypeptides |
US7109292B2 (en) | 1999-03-08 | 2006-09-19 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
DK1169442T3 (da) | 1999-03-23 | 2006-10-16 | Genentech Inc | Secernerede polypeptider og transmembran-polypeptider og nukleinsyrer, der koder for disse |
EP1074617A3 (en) | 1999-07-29 | 2004-04-21 | Research Association for Biotechnology | Primers for synthesising full-length cDNA and their use |
JP4373637B2 (ja) | 1999-08-12 | 2009-11-25 | アジェンシス,インコーポレイテッド | ヒト前立腺癌において発現されるc型レクチン膜貫通抗原およびその使用 |
US7555263B1 (en) * | 1999-10-21 | 2009-06-30 | Broadcom Corporation | Adaptive radio transceiver |
US7300758B2 (en) | 1999-12-09 | 2007-11-27 | Genetech, Inc. | Nucleic acid underexpressed in esophageal tumor |
DE60129547T2 (de) * | 2000-03-21 | 2008-04-17 | Mitsubishi Rayon Co., Ltd. | Verfahren zur kultivierung von mikroorganismen |
US7442765B2 (en) | 2000-08-24 | 2008-10-28 | Genentech, Inc. | Secreted transmembrane polypeptides and nucleic acids encoding the same |
US20030125521A1 (en) | 2001-06-20 | 2003-07-03 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
JP3921367B2 (ja) * | 2001-09-26 | 2007-05-30 | 日本電気株式会社 | データ処理装置および方法、コンピュータプログラム、情報記憶媒体、並列演算装置、データ処理システム |
JP2004187620A (ja) | 2002-12-13 | 2004-07-08 | Sumitomo Pharmaceut Co Ltd | 腎疾患の疾患マーカーおよびその利用 |
US20090068098A1 (en) | 2007-08-20 | 2009-03-12 | Kanner Steven B | Antibodies and related molecules that bind to 58p1d12 proteins |
-
2000
- 2000-08-11 JP JP2001517695A patent/JP4373637B2/ja not_active Expired - Fee Related
- 2000-08-11 ES ES08163095T patent/ES2355428T3/es not_active Expired - Lifetime
- 2000-08-11 DK DK08163095.6T patent/DK1992695T3/da active
- 2000-08-11 AU AU66351/00A patent/AU774436B2/en not_active Ceased
- 2000-08-11 AT AT00953992T patent/ATE420175T1/de active
- 2000-08-11 IL IL14790200A patent/IL147902A0/xx unknown
- 2000-08-11 WO PCT/US2000/022065 patent/WO2001012811A1/en active Application Filing
- 2000-08-11 CA CA2380550A patent/CA2380550C/en not_active Expired - Fee Related
- 2000-08-11 EP EP00953992A patent/EP1200590B1/en not_active Expired - Lifetime
- 2000-08-11 AT AT08163095T patent/ATE486938T1/de active
- 2000-08-11 EP EP08163095A patent/EP1992695B1/en not_active Expired - Lifetime
- 2000-08-11 ES ES00953992T patent/ES2317846T3/es not_active Expired - Lifetime
- 2000-08-11 DK DK00953992T patent/DK1200590T3/da active
- 2000-08-11 US US09/638,203 patent/US6602501B1/en not_active Expired - Fee Related
- 2000-08-11 DE DE60045201T patent/DE60045201D1/de not_active Expired - Lifetime
- 2000-08-11 PT PT00953992T patent/PT1200590E/pt unknown
- 2000-08-11 PT PT08163095T patent/PT1992695E/pt unknown
- 2000-08-11 DE DE60041333T patent/DE60041333D1/de not_active Expired - Lifetime
-
2002
- 2002-01-30 IL IL147902A patent/IL147902A/en not_active IP Right Cessation
-
2003
- 2003-06-11 US US10/460,512 patent/US7153940B2/en not_active Expired - Fee Related
-
2004
- 2004-07-23 US US10/898,615 patent/US7087718B2/en not_active Expired - Fee Related
- 2004-07-23 US US10/897,911 patent/US7148337B2/en not_active Expired - Fee Related
- 2004-07-30 AU AU2004203513A patent/AU2004203513B2/en not_active Ceased
-
2006
- 2006-03-27 JP JP2006086726A patent/JP2006204306A/ja active Pending
- 2006-08-11 AU AU2006203476A patent/AU2006203476A1/en not_active Abandoned
- 2006-10-10 US US11/546,459 patent/US7598045B2/en not_active Expired - Fee Related
-
2009
- 2009-01-28 AU AU2009200299A patent/AU2009200299B2/en not_active Ceased
- 2009-02-13 AU AU2009200576A patent/AU2009200576B2/en not_active Ceased
- 2009-03-16 CY CY20091100289T patent/CY1110256T1/el unknown
- 2009-04-05 IL IL197988A patent/IL197988A/en not_active IP Right Cessation
- 2009-07-23 JP JP2009172429A patent/JP2009235109A/ja active Pending
- 2009-10-01 US US12/572,200 patent/US8022174B2/en not_active Expired - Fee Related
-
2011
- 2011-01-31 CY CY20111100104T patent/CY1111147T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL147902A0 (en) | C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof | |
WO2004113571A3 (en) | Prostate specific genes and the use thereof as targets for prostate cancer therapy and diagnosis | |
WO2002046477A3 (en) | Endogenous retroviruses up-regulated in prostate cancer | |
TR200201442T2 (tr) | Ağrı hafifletme, kemik kanseri terapisi ve kemik yüzeyinin sağlıklı tutulması için kireçlenmiş hedef dokulara yönelik radyum-223 hazırlanması ve kullanımı. | |
AU9312198A (en) | Genes amplified in tumours, antibodies against the proteins encoded thereby, andtheir use in diagnosis and treatment of cancer | |
WO2002076548A3 (en) | Methods and apparatus for treating diseased tissue | |
AU3391200A (en) | Compositions and methods for breast cancer therapy and diagnosis | |
WO2003070889A3 (en) | Prostate specific genes and the use thereof in design or therapeutics | |
AU2002313726A1 (en) | Compositions and methods for the therapy and diagnosis of breast cancer | |
IL207012A (en) | 28sgp medicinal product and 28sgp accent cancer treatment vaccine | |
MXPA02011563A (es) | Composicionesy metodos para la terapia y diagnostico de cancer de seno. | |
EP2365081A3 (en) | 13 Transmembrane protein expressed in prostate cancer | |
AU2001233912A1 (en) | Diagnosis of breast cancer using bcmp-81 as marker | |
IL151335A (en) | 103p2d6: tissue specific protein highly expressed in various cancers | |
EP0967276A3 (en) | Anti-tumor agent comprising salmosin | |
WO2001055391A3 (en) | 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer | |
WO2000035469A3 (en) | hCG THERAPY FOR THE TREATMENT OF BREAST CANCER | |
AU2002253899A1 (en) | Compositions and methods for the therapy and diagnosis of breast cancer | |
AU2002228940A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
WO2001059110A3 (en) | 34p3d7: a tissue specific protein highly expressed in prostate cancer | |
WO2001059115A3 (en) | 83p5g4: a tissue specific protein highly expressed in prostate cancer | |
WO2003020954A3 (en) | 205p1b5 in treatment and detection of cancer | |
WO2001098339A3 (en) | Compositions and methods for the therapy and diagnosis of breast cancer | |
WO2000061610A3 (en) | Prostate-restricted gene 30p3c8 expressed in prostate cancer | |
AU4209097A (en) | Breast carcinoma-associated gene |